Literature DB >> 2468632

Inhibition of intracellular bleomycin hydrolase activity by E-64 leads to the potentiation of the cytotoxicity of peplomycin against Chinese hamster lung cells.

C Nishimura1, T Nishimura, N Tanaka, H Yamaguchi, H Suzuki.   

Abstract

N-(N-(L-3-trans-carboxyoxiran-2-carbonyl)-L-leucyl)-agmatine (E-64), a thiol protease inhibitor, potentiated the cytotoxicity of peplomycin against the Chinese hamster lung (V79) cell. After the treatment of the cells with E-64 (50 micrograms/ml) for 12 h, bleomycin hydrolase activity of the cells was almost completely inhibited. V79 cells treated with [3H]peplomycin for 24 h in the presence of E-64 (50 micrograms/ml) accumulated twice as much [3H]peplomycin and five times less [3H]desamidopeplomycin compared with V79 cells treated in the absence of E-64. These results suggest that E-64 increases the sensitivity of V79 cells to peplomycin probably by inhibiting the intracellular bleomycin hydrolase activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468632      PMCID: PMC5917688          DOI: 10.1111/j.1349-7006.1989.tb02246.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


bleomycin BLM hydrolase peplomycin high‐performance liquid chromatography
  13 in total

1.  In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

2.  Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.

Authors:  C Nishimura; T Nishimura; N Tanaka; H Suzuki
Journal:  J Antibiot (Tokyo)       Date:  1987-12       Impact factor: 2.649

3.  Studies on the mechanism of antitumor effect of bleomycin of squamous cell carcinoma.

Authors:  H Umezawa; T Takeuchi; S Hori; T Sawa; M Ishizuka
Journal:  J Antibiot (Tokyo)       Date:  1972-07       Impact factor: 2.649

4.  Potentiation by squalene of the cytotoxicity of anticancer agents against cultured mammalian cells and murine tumor.

Authors:  M Nakagawa; T Yamaguchi; H Fukawa; J Ogata; S Komiyama; S Akiyama; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1985-04

5.  Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolase.

Authors:  S M Sebti; J C DeLeon; J S Lazo
Journal:  Biochemistry       Date:  1987-07-14       Impact factor: 3.162

6.  Purification of bleomycin hydrolase with a monoclonal antibody and its characterization.

Authors:  C Nishimura; N Tanaka; H Suzuki; N Tanaka
Journal:  Biochemistry       Date:  1987-03-24       Impact factor: 3.162

7.  Mechanisms affecting peplomycin sensitivity of Chinese hamster cell lines.

Authors:  S Ozawa; A Tamura; H Suzuki; T Nishimura; N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1985-09       Impact factor: 2.649

8.  Bleomycin hydrolase activity and cytotoxicity in human tumors.

Authors:  J S Lazo; C J Boland; P E Schwartz
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

9.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Antitumor effect of a combination of 6-methylthioinosine and amphotericin B on mouse leukemia L1210.

Authors:  S I Akiyama; M Kuwano; S Komiyama; M Saneyoshi
Journal:  Cancer Lett       Date:  1980-06       Impact factor: 8.679

View more
  1 in total

1.  Synergistic effect in culture of bleomycin-group antibiotics and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, a synthetic isoprenoid.

Authors:  A Tomida; H Suzuki
Journal:  Jpn J Cancer Res       Date:  1990-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.